Donald defended his PhD thesis at the University of Bristol in 2018. He studied the interaction of the circadian clock and signal transduction networks in plants. After completing his studies, he worked for a regulated molecular diagnostics laboratory that provided a clinically supported service to public and private healthcare clients. In 2021, Donald joined the national COVID-19 response, and was a pivotal member of the development team that developed and validated the high-throughput diagnostic services at the Rosalind Franklin Laboratory ‘Megalab’. Donald now specialises in the design, development and operationalisation of high throughput automated laboratory workflows with expertise spanning both wet lab and software development.